Literature DB >> 2102283

Comparison of the descriptive epidemiology of urinary tract cancers.

S S Devesa1, D T Silverman, J K McLaughlin, C C Brown, R R Connelly, J F Fraumeni.   

Abstract

We compared the descriptive epidemiology of several urinary tract cancers, utilizing incidence data from the United States and international sources. The patterns of cancers of the renal pelvis, ureter, and urethra were more similar to those of bladder cancer than to cancer of the renal parenchyma in several ways: (i) transitional cell carcinoma is the predominant histologic type in the renal pelvis, ureter, urethra, and bladder, whereas the vast majority of renal parenchyma neoplasms are adenocarcinomas; (ii) in situ tumors often appear in all these sites except the renal parenchyma; (iii) rate ratios for renal pelvis/ureter cancers among blacks and Hispanics, relative to whites, are closer to those for bladder than to those for renal parenchymal cancers; (iv) rates among US men and women for cancers of the renal pelvis and ureter are more highly correlated with those for bladder cancer than with those of the renal parenchyma across racial groups; and (v) similar correlations occur among women across geographic areas within the US and internationally. However, the patterns for cancers of the renal pelvis and ureter do not always resemble more closely those for bladder than renal parenchyma cancers and occasionally appear different from one another. These findings indicate the importance of distinguishing tumors based on specific primary site and cell type.

Entities:  

Mesh:

Year:  1990        PMID: 2102283     DOI: 10.1007/bf00053164

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  19 in total

1.  Occupational risks of bladder cancer in the United States: I. White men.

Authors:  D T Silverman; L I Levin; R N Hoover; P Hartge
Journal:  J Natl Cancer Inst       Date:  1989-10-04       Impact factor: 13.506

2.  Risk factors for cancer of the renal parenchyma.

Authors:  M McCredie; J M Ford; J H Stewart
Journal:  Int J Cancer       Date:  1988-07-15       Impact factor: 7.396

3.  Epidemiology of cancer of the renal pelvis and ureter.

Authors:  R Schmauz; P Cole
Journal:  J Natl Cancer Inst       Date:  1974-05       Impact factor: 13.506

4.  Phenacetin and cancers of the urinary tract.

Authors: 
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

5.  Petroleum-related employment and renal cell cancer.

Authors:  J K McLaughlin; W J Blot; E S Mehl; P A Stewart; F S Venable; J F Fraumeni
Journal:  J Occup Med       Date:  1985-09

6.  Surveillance, epidemiology, and end results: incidence and mortality data, 1973-77.

Authors: 
Journal:  Natl Cancer Inst Monogr       Date:  1981-06

7.  The Copenhagen case-control study of renal pelvis and ureter cancer: role of smoking and occupational exposures.

Authors:  O M Jensen; J B Knudsen; J K McLaughlin; B L Sørensen
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

8.  A population--based case--control study of renal cell carcinoma.

Authors:  J K McLaughlin; J S Mandel; W J Blot; L M Schuman; E S Mehl; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1984-02       Impact factor: 13.506

9.  Asbestos and renal adenocarcinoma: a case-control study.

Authors:  M Maclure
Journal:  Environ Res       Date:  1987-04       Impact factor: 6.498

10.  Bladder cancer, drinking water source, and tap water consumption: a case-control study.

Authors:  K P Cantor; R Hoover; P Hartge; T J Mason; D T Silverman; R Altman; D F Austin; M A Child; C R Key; L D Marrett
Journal:  J Natl Cancer Inst       Date:  1987-12       Impact factor: 13.506

View more
  19 in total

Review 1.  Should there be a size limit for elective nephron-sparing surgery?

Authors:  Kent G Krejci; Bradley C Leibovich
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

2.  Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

Review 3.  Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma.

Authors:  Bryden Considine; Michael E Hurwitz
Journal:  Curr Oncol Rep       Date:  2019-03-08       Impact factor: 5.075

4.  Increased risk of renal cell cancer among women using diuretics in the United States.

Authors:  W D Finkle; J K McLaughlin; S A Rasgon; H H Yeoh; J E Low
Journal:  Cancer Causes Control       Date:  1993-11       Impact factor: 2.506

5.  Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.

Authors:  Kelly L Stratton; Shaheen Alanee; Emily A Glogowski; Kasmintan A Schrader; Rohini Rau-Murthy; Robert Klein; Paul Russo; Jonathan Coleman; Kenneth Offit
Journal:  Urol Oncol       Date:  2015-12-23       Impact factor: 3.498

6.  Diet, obesity and risk for renal cell carcinoma: results from a case control-study in Germany.

Authors:  H Boeing; B Schlehofer; J Wahrendorf
Journal:  Z Ernahrungswiss       Date:  1997-03

7.  Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Peter R Mueller; Chin Hur; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

8.  Dietary fat and risk of renal cell carcinoma in the USA: a case-control study.

Authors:  Kaye E Brock; Gloria Gridley; Brian C-H Chiu; Abby G Ershow; Charles F Lynch; Kenneth P Cantor
Journal:  Br J Nutr       Date:  2008-09-12       Impact factor: 3.718

9.  Occupational risk factors for renal cell carcinoma: a case-control study.

Authors:  A Aupérin; S Benhamou; C Ory-Paoletti; R Flamant
Journal:  Occup Environ Med       Date:  1994-06       Impact factor: 4.402

10.  Mortality and cancer morbidity in workers from an aluminium smelter with prebaked carbon anodes--Part II: Cancer morbidity.

Authors:  A Rønneberg; A Andersen
Journal:  Occup Environ Med       Date:  1995-04       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.